Role of free radical and antioxidant imbalance in pathogenesis of Parkinson's disease

Biomedical Research

Volumn 20, Issue 1, 2009, Pages 55-58

  Nikam, Shashikant ^a   Nikam, Padmaja ^a   Ahaley, S K ^b  

^a Belgaum Institute of Medical Sciences   (India)

^b Government Medical College   (India)

Author keywords

Antioxidants; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CERULOPLASMIN; COPPER; DOPAMINE; FREE RADICAL; GLUTATHIONE PEROXIDASE; LIPID; NITRIC OXIDE; SELENIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ZINC;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ERYTHROCYTE LEVEL; EXCITOTOXICITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NERVE CELL DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; SUBSTANTIA NIGRA;

EID: 65549131949     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Josep BM. Moleculor basis of the neurodegenerative disorder. New.Eng.J.of Med1999; 340: 1970-1980.
2. Erik PP. Antioxidant therapy in ALS. ALS and other motor neuron disorders. 2000; Suppl.14:5-15.
3. Kowall W, Ferante RJ, Martin JB. Patterns of cells in Huntington's disease. Trends Neuroscie. 1987; 10: 42-49.
4. Mmosley RL, Eric JBenner, Irena P. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease.Clin.Neurochem.Res.2006; 6: 261-281.
5. Jellinger K. Pathology of Parkinson's disease, changes other than the nigrostritalpathway. Ann.neural. 1992; 14: 153-197.
6. Forne LS. Pathology of Parkinson's disease and importance of substentia nigra and Lewy bodies. Aetiology of Parkinson's disease. Ed.Sterm. G.Baltimore Johns Hopkins Press: 1990; p 185-238.
7. Kurtz JF. An overview of epidemiology of Parkinsonism. Progress in Parkinson's disease research. Eds. Hefti F, Weiner W.J. Mount Kisw Futura Publishing Company. 1992; p-119-169.
8. Munch G. Oxidative stress and advanced glycation end products. Alzheimer's disease review. 1996;1:71-74.
9. Benecke R, Strumper P, Weiss H. Electron transport complex CI & IV of platelets are abnormal in Parkinson's disease. Brain. 1993; 116; 1451-1463.
10. Buege JA,. Aust AD. Microsomal lipid peroxidation.In methods Enzymeol Estbrook RW, Pullman ME. New York: Acad Press. 1987;302-10
11. Baker FS and Frank H. Vitamin E. In clinical vitaminology methods & interpretation, Interscience publishers, New York. 1968; 169-176.
12. Natelson S. Ascorbic acid. In techniques of clinical chemistry, 3rd Edition, Charles C Thomas, Illinios USA. 1971; 162-165.
13. Karl H, Smith BSW, Wright H. Colorimetric method for serum Ceruloplasmin Clin Chem 1974; 50: 359-366.
14. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.Arch.Biochem.Biophysics.1978; 186,189-195.
15. Beutler F, Duron O,Kelly BM. Improved method for determination of blood glutathione. Lab Clin Med 1963; 61:882-888.
16. Aebi H. Catalase. In methods, in enzymatic analysis (ed) Bergmeryer HU. Vol. 3. Acadamic press New York 1983; 276-286.
17. Cortas WL, Walkid HS. Determination of nitrate in serum and urine by kinetic cadmium reduction method. Clinical Chem. 1990; 38: 1440-1443.
18. Fahn S. Parkinson's disease and other basal ganglion disorders. IN: Disease of nervous system. Clinical Neurology. Eds.: Asbury A.K. et.al W.B. Saunders compney. 1992; 1144-1158.
19. Ratan R.R.& Baraban J.M. Apoptotic death in an invitro model of neuronal oxidative stress. Clincal. Ext Pharmacol Physica 1995; 309-310.
20. Mecocci CC. The oxidative damage mitochondrial DNA shows age dependent increase in human brain. Ann neural. 1993: 34; 159-163.
21. Floryed RA. Antioxidants,oxidative stress and degenerative neurological disorders.Proc.Soc.Exper.Biol.Med. 1999; 222: 236-45
22. Behl C, Davis J, Cole GM. Vitamin E protects nerves cells from amyloid beta protein toxicity. Biochem. Biophy Res Commun 1992; 186: 944-950.
23. Brown R. ALS and the inherited motor neurons disease. Mol Neurol New York Scientific Americam. 1998; 223: 238-241.
24. Burke RE. Apoptosis in degenerative disease of the basal ganglia. Neurosciertist. 1998; 4: 301-311.
25. Bhumik D, Medin J, Gathyk C. Mutational analysis of active site residue of human adenosine deaminase. J Biol Chem. 1993; 8268: 5461-5470.